FDA Drug Application (203568) for KYNAMRO by KASTLE THERAPS LLC

Back to FDA Applications sponsored by KASTLE THERAPS LLC

Application Number203568
Product Number001
FormSOLUTION;SUBCUTANEOUS
Dosage200MG/ML (200MG/ML)
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameKYNAMRO
Active IngredientMIPOMERSEN SODIUM



Back to FDA Applications sponsored by KASTLE THERAPS LLC